Search - tctmd.com

Displaying 641 - 660 of 1755

Sort: Relevancy | Date

News Industry News

DalCor Randomizes First Patient in the DalGenE Phase 3 Cardiovascular Outcomes Trial

April 26, 2016

News Daily News

低体重指数本身预测急性心梗后生存率不佳

Caitlin E. Cox

April 21, 2016

News Daily News

Un IMC Bajo Per Se Acarrea una Mala Supervivencia Después de Sufrir un IAM

Caitlin E. Cox

April 21, 2016

News Conference News ACC 2016

Toker’s Paradox? Marijuana Users Face Lower Short-Term Risks After Acute MI, Study Hints

Todd Neale

April 11, 2016

News Conference News ACC 2016

EARLY-BAMI: No Reduction in Infarct Size With IV Metoprolol Before Primary PCI

Caitlin E. Cox

April 03, 2016

News Daily News

CAD Extent May Foreshadow Risk of Heart Failure After First MI

L.A. McKeown

March 31, 2016

News Daily News

研究表明由于某些危险因素逐渐攀升，导致预防心梗的效果有所减弱

L.A. McKeown

March 28, 2016

News Daily News

Un Estudio Sugiere que los Esfuerzos para la Prevención de IM están Fracasando con el Aumento de Ciertos Factores de Riesgo

L.A. McKeown

March 28, 2016

News Daily News

Study Suggests MI Prevention Efforts Slipping, as Certain Risk Factors Creep Higher

L.A. McKeown

March 28, 2016

News Daily News

Evidence Mounts Showing No Increased Risk of Heart Failure With Incretin-Based Antidiabetic Drugs

Michael O'Riordan

March 25, 2016

News Daily News

急性心梗后随访延迟导致服药依从性降低

Todd Neale

March 24, 2016

News Daily News

Medication Adherence Suffers With Delayed Follow-up After Acute MI

Todd Neale

March 24, 2016

News Daily News

New Analysis of COGENT Supports PPI Use in Patients on Low-Dose Aspirin

Caitlin E. Cox

March 23, 2016

News Industry News

Aralez resubmits to FDA New Drug Application for YOSPRALA

March 15, 2016

News Daily News

Elevated Triglycerides Linked to All-Cause Mortality and Coronary Artery Disease

Michael O'Riordan

March 07, 2016

News Industry News

Victoza® Significantly Reduced the Risk of Major Adverse Cardiovascular Events in the LEADER Trial

March 06, 2016

News Daily News

Postpone Noncardiac Surgery at Least a Year in Patients with Stents of Any Type: Registry Analysis

L.A. McKeown

March 01, 2016

News Industry News

New Haven Pharmaceuticals Presents Positive Data That Shows DURLAZA™ is Well Tolerated and Delivers Sustained 24-hour Antiplatelet Control

March 01, 2016

News Industry News

STENTYS: Results of Self-Apposing Sirolimus-Eluting Stent Trial Published in EuroIntervention

February 28, 2016

News Industry News

Micell Technologies Highlights Data From Published Propensity Analysis of MiStent SES® and Market Standard Xience V® Coronary Stent

February 24, 2016

Advertisement

DalCor Randomizes First Patient in the DalGenE Phase 3 Cardiovascular Outcomes Trial

低体重指数本身预测急性心梗后生存率不佳

Un IMC Bajo Per Se Acarrea una Mala Supervivencia Después de Sufrir un IAM

Toker’s Paradox? Marijuana Users Face Lower Short-Term Risks After Acute MI, Study Hints

EARLY-BAMI: No Reduction in Infarct Size With IV Metoprolol Before Primary PCI

CAD Extent May Foreshadow Risk of Heart Failure After First MI

研究表明由于某些危险因素逐渐攀升，导致预防心梗的效果有所减弱

Un Estudio Sugiere que los Esfuerzos para la Prevención de IM están Fracasando con el Aumento de Ciertos Factores de Riesgo

Study Suggests MI Prevention Efforts Slipping, as Certain Risk Factors Creep Higher

Evidence Mounts Showing No Increased Risk of Heart Failure With Incretin-Based Antidiabetic Drugs

急性心梗后随访延迟导致服药依从性降低

Medication Adherence Suffers With Delayed Follow-up After Acute MI

New Analysis of COGENT Supports PPI Use in Patients on Low-Dose Aspirin

Aralez resubmits to FDA New Drug Application for YOSPRALA

Elevated Triglycerides Linked to All-Cause Mortality and Coronary Artery Disease

Victoza® Significantly Reduced the Risk of Major Adverse Cardiovascular Events in the LEADER Trial

Postpone Noncardiac Surgery at Least a Year in Patients with Stents of Any Type: Registry Analysis

New Haven Pharmaceuticals Presents Positive Data That Shows DURLAZA™ is Well Tolerated and Delivers Sustained 24-hour Antiplatelet Control

STENTYS: Results of Self-Apposing Sirolimus-Eluting Stent Trial Published in EuroIntervention

Micell Technologies Highlights Data From Published Propensity Analysis of MiStent SES® and Market Standard Xience V® Coronary Stent

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content